Clinical trial
Antiplatelet Therapy in Acute Coronary Syndrome (ACS). Safety and Efficacy of Switching Antiplatelet
NCT02500290 is registered in ClinicalTrials.gov with Fundación Pública Andaluza Progreso y Salud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiplatelet Therapy in Acute Coronary Syndrome (ACS). Safety and Efficacy of Switching Antiplatelet
- Lead sponsor
- Fundación Pública Andaluza Progreso y Salud
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- March 31, 2021
- Enrollment
- 2,000 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.